<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8902615</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1463</journal-id>
<journal-id journal-id-type="nlm-ta">J Chem Neuroanat</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Chem. Neuroanat.</journal-id>
<journal-title-group>
<journal-title>Journal of chemical neuroanatomy</journal-title>
</journal-title-group>
<issn pub-type="ppub">0891-0618</issn>
<issn pub-type="epub">1873-6300</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28213183</article-id>
<article-id pub-id-type="pmc">5555828</article-id>
<article-id pub-id-type="doi">10.1016/j.jchemneu.2017.02.001</article-id>
<article-id pub-id-type="manuscript">NIHMS855080</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>“A Role for the Serotonin Reuptake “Transporter in the Brain and Intestinal Features of Autism Spectrum Disorders and Developmental Antidepressant Exposure”</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Margolis</surname>
<given-names>Kara Gross</given-names>
</name>
<degrees>MD</degrees>
<role>Associate Professor of Pediatrics</role>
<aff id="A1">Division of Pediatric Gastroenterology, Hepatology and NutritionMorgan Stanley Children's Hospital, Columbia University Medical Center</aff>
</contrib>
</contrib-group>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>83-84</volume>
<fpage>36</fpage>
<lpage>40</lpage>
<!--elocation-id from pubmed: 10.1016/j.jchemneu.2017.02.001-->
<abstract>
<p id="P1">Many disease conditions considered CNS-predominant harbor significant intestinal comorbidities. Serotonin (5-HT) and the serotonin reuptake transporter (SERT) have increasingly been shown to play important roles in both brain and intestinal development and long-term function. 5-HT and SERT may thus modulate critical functions in the development and perpetuation of brain-gut axis disease. We discuss the potential roles of 5-HT and SERT in the brain and intestinal manifestations of autism spectrum disorders and developmental antidepressant exposure. The potential therapeutic value of 5-HT<sub>4</sub> modulation in the subsequent treatment of these conditions is also addressed.</p>
</abstract>
<kwd-group>
<kwd>serotonin</kwd>
<kwd>serotonin reuptake transporter</kwd>
<kwd>autism spectrum disorders</kwd>
<kwd>antidepressants</kwd>
<kwd>selective serotonin reuptake inhibitors</kwd>
<kwd>brain-gut axis</kwd>
<kwd>5-HT<sub>4</sub> receptor</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>